176P Assessing the duration of maintenance immunotherapy in metastatic lung cancer patients: A retrospective review

Immunotherapy has served as a game-changing therapy for patients with metastatic non-small cell lung cancer, however, there are no clear recommendations as to what the duration of treatment should be. Our study objective was to review the duration of maintenance immunotherapy in our cohort of patients.